Onco Nano Medicine Appoints Dr. Kartik Krishnan As Chief Executive Officer and Dr. Melissa Paoloni As Executive Vice President and Chief Operating Officer
Onco Nano Medicine Appoints Dr. Kartik Krishnan As Chief Executive Officer and Dr. Melissa Paoloni As Executive Vice President and Chief Operating Officer
03/01/24, 1:12 PM
Location
southlakeIndustry
therapeutics
medical
biotechnology
health care
Position
chief executive officer
OncoNano Medicine, Inc. announces the appointment of Dr. Kartik Krishnan, MD, PhD to Chief Executive Officer (CEO) and member of the Board of Directors, succeeding Martin Driscoll
Company Info
Location
southlake, texas, united states
Additional Info
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents. Our lead program, ONM-100, targets tumor acidosis to accurately differentiate cancer from healthy tissue for use in surgery.